Weight loss outcomes and complications from bariatric surgery in the super super obese

Oscar K. Serrano, Jonathan E. Tannebaum, Lindsay Cumella, Jenny J. Choi, Pratibha Vemulapalli, W. Scott Melvin, Diego Camacho

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background: Bariatric surgery has been established as the most effective long-term treatment for morbid obesity. Methods: We performed a retrospective review of SSO patients treated at our institute between 2008 and 2013 who underwent a laparoscopic gastric bypass (LGBP) or sleeve gastrectomy (LSG). The primary end point for this study was excess weight loss (EWL) at 1, 3, 6, and 12 months. Secondary end points included procedure length (PL), length of stay (LOS), diabetes management and postoperative complications. Results: We identified 135 SSO patients who underwent bariatric surgery (93 LGBP, 42 LSG) at our institute from 2008 to 2013 with a median follow-up of 49 months. The incidence of EWL > 30 % for patients in the LGBP group was 3.9, 29.0, 72.2 and 94.6 % at 1, 3, 6 and 12 months, respectively, while the incidence of EWL > 30 % in patients in the LSG group was 4.2, 25.0, 59.1 and 100 % at 1, 3, 6 and 12 months, respectively. PL was 124 ± 49 min for the LGBP group and 98 + 51 min for the LSG group (p < 0.005). LOS was on average 3.0 days (range 1–21) for the LGBP group and 3.4 days (range 1–13) for the LSG group (p = 0.41). Patients experienced a decrease in their hemoglobin A1C level by 10 % for the LGBP group and 9 % for the LSG group at 1 year (p = 0.89). Postoperative complications were seen in 15.1 % of LGBP patients and 4.8 % of LSG patients. Conclusions: Bariatric surgery is feasible in the SSO patients with comparable EWL outcomes and postoperative complications to historical non-SSO patients.

Original languageEnglish (US)
JournalSurgical Endoscopy and Other Interventional Techniques
DOIs
StateAccepted/In press - Aug 25 2015

Fingerprint

Bariatric Surgery
Gastric Bypass
Weight Loss
Gastrectomy
Length of Stay
Morbid Obesity
Incidence
Diabetes Complications
Hemoglobins

Keywords

  • Bariatric surgery
  • Excess weight loss
  • Laparoscopic Roux-en-Y gastric bypass
  • Laparoscopic sleeve gastrectomy
  • Super super obese

ASJC Scopus subject areas

  • Surgery

Cite this

Weight loss outcomes and complications from bariatric surgery in the super super obese. / Serrano, Oscar K.; Tannebaum, Jonathan E.; Cumella, Lindsay; Choi, Jenny J.; Vemulapalli, Pratibha; Melvin, W. Scott; Camacho, Diego.

In: Surgical Endoscopy and Other Interventional Techniques, 25.08.2015.

Research output: Contribution to journalArticle

@article{c40d49db6a944b57b1a3b1603d7ea440,
title = "Weight loss outcomes and complications from bariatric surgery in the super super obese",
abstract = "Background: Bariatric surgery has been established as the most effective long-term treatment for morbid obesity. Methods: We performed a retrospective review of SSO patients treated at our institute between 2008 and 2013 who underwent a laparoscopic gastric bypass (LGBP) or sleeve gastrectomy (LSG). The primary end point for this study was excess weight loss (EWL) at 1, 3, 6, and 12 months. Secondary end points included procedure length (PL), length of stay (LOS), diabetes management and postoperative complications. Results: We identified 135 SSO patients who underwent bariatric surgery (93 LGBP, 42 LSG) at our institute from 2008 to 2013 with a median follow-up of 49 months. The incidence of EWL > 30 {\%} for patients in the LGBP group was 3.9, 29.0, 72.2 and 94.6 {\%} at 1, 3, 6 and 12 months, respectively, while the incidence of EWL > 30 {\%} in patients in the LSG group was 4.2, 25.0, 59.1 and 100 {\%} at 1, 3, 6 and 12 months, respectively. PL was 124 ± 49 min for the LGBP group and 98 + 51 min for the LSG group (p < 0.005). LOS was on average 3.0 days (range 1–21) for the LGBP group and 3.4 days (range 1–13) for the LSG group (p = 0.41). Patients experienced a decrease in their hemoglobin A1C level by 10 {\%} for the LGBP group and 9 {\%} for the LSG group at 1 year (p = 0.89). Postoperative complications were seen in 15.1 {\%} of LGBP patients and 4.8 {\%} of LSG patients. Conclusions: Bariatric surgery is feasible in the SSO patients with comparable EWL outcomes and postoperative complications to historical non-SSO patients.",
keywords = "Bariatric surgery, Excess weight loss, Laparoscopic Roux-en-Y gastric bypass, Laparoscopic sleeve gastrectomy, Super super obese",
author = "Serrano, {Oscar K.} and Tannebaum, {Jonathan E.} and Lindsay Cumella and Choi, {Jenny J.} and Pratibha Vemulapalli and Melvin, {W. Scott} and Diego Camacho",
year = "2015",
month = "8",
day = "25",
doi = "10.1007/s00464-015-4509-y",
language = "English (US)",
journal = "Surgical Endoscopy and Other Interventional Techniques",
issn = "0930-2794",
publisher = "Springer New York",

}

TY - JOUR

T1 - Weight loss outcomes and complications from bariatric surgery in the super super obese

AU - Serrano, Oscar K.

AU - Tannebaum, Jonathan E.

AU - Cumella, Lindsay

AU - Choi, Jenny J.

AU - Vemulapalli, Pratibha

AU - Melvin, W. Scott

AU - Camacho, Diego

PY - 2015/8/25

Y1 - 2015/8/25

N2 - Background: Bariatric surgery has been established as the most effective long-term treatment for morbid obesity. Methods: We performed a retrospective review of SSO patients treated at our institute between 2008 and 2013 who underwent a laparoscopic gastric bypass (LGBP) or sleeve gastrectomy (LSG). The primary end point for this study was excess weight loss (EWL) at 1, 3, 6, and 12 months. Secondary end points included procedure length (PL), length of stay (LOS), diabetes management and postoperative complications. Results: We identified 135 SSO patients who underwent bariatric surgery (93 LGBP, 42 LSG) at our institute from 2008 to 2013 with a median follow-up of 49 months. The incidence of EWL > 30 % for patients in the LGBP group was 3.9, 29.0, 72.2 and 94.6 % at 1, 3, 6 and 12 months, respectively, while the incidence of EWL > 30 % in patients in the LSG group was 4.2, 25.0, 59.1 and 100 % at 1, 3, 6 and 12 months, respectively. PL was 124 ± 49 min for the LGBP group and 98 + 51 min for the LSG group (p < 0.005). LOS was on average 3.0 days (range 1–21) for the LGBP group and 3.4 days (range 1–13) for the LSG group (p = 0.41). Patients experienced a decrease in their hemoglobin A1C level by 10 % for the LGBP group and 9 % for the LSG group at 1 year (p = 0.89). Postoperative complications were seen in 15.1 % of LGBP patients and 4.8 % of LSG patients. Conclusions: Bariatric surgery is feasible in the SSO patients with comparable EWL outcomes and postoperative complications to historical non-SSO patients.

AB - Background: Bariatric surgery has been established as the most effective long-term treatment for morbid obesity. Methods: We performed a retrospective review of SSO patients treated at our institute between 2008 and 2013 who underwent a laparoscopic gastric bypass (LGBP) or sleeve gastrectomy (LSG). The primary end point for this study was excess weight loss (EWL) at 1, 3, 6, and 12 months. Secondary end points included procedure length (PL), length of stay (LOS), diabetes management and postoperative complications. Results: We identified 135 SSO patients who underwent bariatric surgery (93 LGBP, 42 LSG) at our institute from 2008 to 2013 with a median follow-up of 49 months. The incidence of EWL > 30 % for patients in the LGBP group was 3.9, 29.0, 72.2 and 94.6 % at 1, 3, 6 and 12 months, respectively, while the incidence of EWL > 30 % in patients in the LSG group was 4.2, 25.0, 59.1 and 100 % at 1, 3, 6 and 12 months, respectively. PL was 124 ± 49 min for the LGBP group and 98 + 51 min for the LSG group (p < 0.005). LOS was on average 3.0 days (range 1–21) for the LGBP group and 3.4 days (range 1–13) for the LSG group (p = 0.41). Patients experienced a decrease in their hemoglobin A1C level by 10 % for the LGBP group and 9 % for the LSG group at 1 year (p = 0.89). Postoperative complications were seen in 15.1 % of LGBP patients and 4.8 % of LSG patients. Conclusions: Bariatric surgery is feasible in the SSO patients with comparable EWL outcomes and postoperative complications to historical non-SSO patients.

KW - Bariatric surgery

KW - Excess weight loss

KW - Laparoscopic Roux-en-Y gastric bypass

KW - Laparoscopic sleeve gastrectomy

KW - Super super obese

UR - http://www.scopus.com/inward/record.url?scp=84939863718&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939863718&partnerID=8YFLogxK

U2 - 10.1007/s00464-015-4509-y

DO - 10.1007/s00464-015-4509-y

M3 - Article

C2 - 26304105

AN - SCOPUS:84939863718

JO - Surgical Endoscopy and Other Interventional Techniques

JF - Surgical Endoscopy and Other Interventional Techniques

SN - 0930-2794

ER -